Vaxcyte president and CFO sells over $900k in stock, a move that has sent ripples through the market and sparked questions about the company’s future. The sales, which occurred amidst a period of significant growth for Vaxcyte, have raised eyebrows among investors and analysts alike. This article delves into the …
Read More »
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.